Literature DB >> 5940924

Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo.

T B Fitzpatrick, K A Arndt, A M el-Mofty, M A Pathak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5940924

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  13 in total

1.  Editorial: Photochemotherapy for psoriasis.

Authors: 
Journal:  Br Med J       Date:  1975-03-01

2.  Psoralen/UVA treatment and chromosomes. I. Aberrations and sister chromatid exchange in human lymphocytes in vitro and synergism with caffeine.

Authors:  H Waksvik; A Brogger; J Stene
Journal:  Hum Genet       Date:  1977-09-22       Impact factor: 4.132

Review 3.  Determination of 8-methoxypsoralen in serum, aqueous, and lens: relation to long-wave ultraviolet phototoxicity in experimental and clinical photochemotherapy.

Authors:  W B Glew
Journal:  Trans Am Ophthalmol Soc       Date:  1979

4.  Effect of 2-deoxy-D-glucose on the liquid-holding reactivation of yeast cells photodamaged by psoralen.

Authors:  V K Jain; R K Biswas; P Chandra
Journal:  Radiat Environ Biophys       Date:  1976-03-30       Impact factor: 1.925

Review 5.  Psoriasis: current concepts in management.

Authors:  L Hodge; J S Comaish
Journal:  Drugs       Date:  1977-04       Impact factor: 9.546

6.  The lens and PUVA therapy.

Authors:  C C Sterk; C A Geldof; H G Ten-Jet-Foei
Journal:  Doc Ophthalmol       Date:  1983-02-28       Impact factor: 2.379

7.  Phenylalanine and UVA light for the treatment of vitiligo.

Authors:  R H Cormane; A H Siddiqui; W Westerhof; R B Schutgens
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

8.  The carcinogenic properties of topical PUVA. A lifelong study in mice.

Authors:  M Hannuksela; F Stenbäck; A Lahti
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

9.  Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling.

Authors:  Wang-Chuan Chen; Tien-Sheng Tseng; Nai-Wan Hsiao; Yun-Lian Lin; Zhi-Hong Wen; Chin-Chuan Tsai; Yu-Ching Lee; Hui-Hsiung Lin; Keng-Chang Tsai
Journal:  Sci Rep       Date:  2015-01-23       Impact factor: 4.379

10.  Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety.

Authors:  Sanggwon Lee; Heejeong Choi; Yujin Park; Hee Jin Jung; Sultan Ullah; Inkyu Choi; Dongwan Kang; Chaeun Park; Il Young Ryu; Yeongmu Jeong; YeJi Hwang; Sojeong Hong; Pusoon Chun; Hyung Ryong Moon
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.